Please login to the form below

Not currently logged in
Email:
Password:

Horizon Discovery appoints executive director

David Smoller is chief business officer at the genomics firm
david-smoller horizon

UK-based genetic research company Horizon Discovery has named Dr David Smoller as an executive director of the board.

Smoller joined Horizon as chief business officer as part of the form's acquisition of Sage Labs for $48m in September this year.

Of his appointment, he said: “The integration of Sage Labs and Horizon is progressing well and I am delighted to be joining the Horizon board at this exciting time for the company.”

His previous roles include the position of CEO at Sage Labs, chief scientific officer of Sigma-Aldrich and president of its research biotechnology business unit.

He also served as president of ProteoPlex, a seed stage spinout focusing on proteomics, which was acquired by Merck KGaA in 2003, and founded Genomes Systems, acquired by Incyte Genomics in 1996.

Horizon is a UK-based biotech focused on genomics research and the development of personalised medicines. It has partnerships with several major pharma companies, including AstraZeneca.

The company has undergone expansion in recent years with other senior appointments including GSK and Abbott veteran Dr Ian Gilham as chairman and the addition of AstraZeneca's head of oncology R&D Susan Galbraith to Horizon's board.

4th November 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics